CARA $4.95 (-2.94%) Quote details
Add to Watchlist Run Backtest
Establish your trading edge with a set of smart tools for serious trades. Upgrade Account
stock

Cara Therapeutic

NASDAQ | CARA

4.95

USD

-0.15 (-2.94%)

AT CLOSE (AS OF Apr 3, 2025)

$23M

MARKET CAP

-

P/E Ratio

-15.53

EPS

$11

52 Week High

$2.7

52 Week Low

LIFE SCIENCES

Sector

CARA Chart

1D
Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests
Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals
Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

CARA Technicals

Tags:

CARA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$32M
Total Revenue $7.1M
Cost Of Revenue $39M
Costof Goods And Services Sold $3M
Operating Income -$58M
Selling General And Administrative $27M
Research And Development $33M
Operating Expenses $66M
Investment Income Net -
Net Interest Income -$8.5M
Interest Income -
Interest Expense $8.5M
Non Interest Income $7.1M
Other Non Operating Income $2.8M
Depreciation -
Depreciation And Amortization $192K
Income Before Tax -$71M
Income Tax Expense -$398K
Interest And Debt Expense -
Net Income From Continuing Operations -$71M
Comprehensive Income Net Of Tax -$71M
Ebit -$58M
Ebitda -$63M
Net Income -$71M

Revenue & Profitability

Earnings Performance

CARA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $44M
Total Current Assets $44M
Cash And Cash Equivalents At Carrying Value $38M
Cash And Short Term Investments $38M
Inventory $900K
Current Net Receivables $4.6M
Total Non Current Assets -
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $529K
Other Non Current Assets -
Total Liabilities $48M
Total Current Liabilities $4M
Current Accounts Payable $1.4M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $50K
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $2.5M
Other Non Current Liabilities $44M
Total Shareholder Equity -$4.6M
Treasury Stock -
Retained Earnings -$756M
Common Stock $5K
Common Stock Shares Outstanding $4.6M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$61M
Payments For Operating Activities $9.9M
Proceeds From Operating Activities -
Change In Operating Liabilities -$26M
Change In Operating Assets -$8.6M
Depreciation Depletion And Amortization $192K
Capital Expenditures $1M
Change In Receivables -$2M
Change In Inventory $1M
Profit Loss -$71M
Cashflow From Investment $49M
Cashflow From Financing -$3.6M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$71M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$32M
Total Revenue $7.1M
Cost Of Revenue $39M
Costof Goods And Services Sold $3M
Operating Income -$58M
Selling General And Administrative $27M
Research And Development $33M
Operating Expenses $66M
Investment Income Net -
Net Interest Income -$8.5M
Interest Income -
Interest Expense $8.5M
Non Interest Income $7.1M
Other Non Operating Income $2.8M
Depreciation -
Depreciation And Amortization $192K
Income Before Tax -$71M
Income Tax Expense -$398K
Interest And Debt Expense -
Net Income From Continuing Operations -$71M
Comprehensive Income Net Of Tax -$71M
Ebit -$58M
Ebitda -$63M
Net Income -$71M

CARA Profile

Cara Therapeutic Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on itching and pain by selectively targeting kappa opioid receptors in the United States. The company is headquartered in Stamford, Connecticut.

DMN
9.42%
$0.0151
NVDA
-7.81%
$101.8
INTC
2.05%
$22.43
F
-5.96%
$9.545
LCID
-3.33%
$2.32
STSS
8.79%
$0.0297
PTIX
84.14%
$0.418
LGMK
-15.96%
$0.0158
TSLA
-5.47%
$267.28
BAC
-11.06%
$37.22
NIVF
-4.75%
$0.561
MGOL
-20.43%
$0.37
DGLY
9.09%
$0.036
AAPL
-9.25%
$203.19
AMZN
-8.98%
$178.41
PLTR
-4.40%
$83.6
ALTM
0.00%
$5.84
OSRH
68.03%
$2.47
LILM
-36.97%
$0.052
AAL
-10.25%
$9.505
APVO
44.20%
$1.99
SOFI
-13.57%
$10.64
BON
-12.81%
$0.0633
NKE
-14.59%
$55.485
BTE
-10.54%
$1.995
GNPX
46.31%
$0.4316
HOOD
-10.36%
$38.26
DNN
-4.23%
$1.245
MULN
-22.82%
$0.0795
BBD
3.30%
$2.29
LYT
-16.78%
$0.0982
MRM
87.76%
$0.6947
PFE
-1.66%
$24.29
BTG
0.00%
$2.92
VALE
-3.57%
$9.73
WBD
-13.26%
$9.16
PMAX
-2.68%
$0.435
SNAP
-9.74%
$8.015
JYD
24.25%
$0.4293
AMD
-8.90%
$93.8
PLUG
-8.33%
$1.21
T
1.63%
$28.6
ABEV
2.54%
$2.42
CCL
-13.69%
$17.28
GOOGL
-4.02%
$150.72
MU
-16.09%
$74.34
SMCI
-7.89%
$32.32
AVGO
-10.51%
$154.01
RIG
-13.92%
$2.72
LYG
-4.56%
$3.665
CSCO
-7.30%
$57.31
C
-12.14%
$63.05
RIVN
-7.69%
$11.53
JBLU
-17.36%
$4.165
AGNC
-1.48%
$9.34
KSS
-22.79%
$6.64
NKLA
-28.74%
$0.183
NIO
-1.32%
$3.75
ITUB
2.71%
$5.68
UAA
-18.79%
$5.36
HPE
-15.23%
$13.665
ATPC
-0.78%
$1.28
TIVC
49.85%
$4.87
VFC
-28.80%
$11.67
AMCR
-2.50%
$9.555
META
-8.96%
$531.62
CLF
-16.90%
$7.255
WMT
-2.83%
$87.22
IQ
-4.57%
$2.09
STLA
-9.36%
$10.215
FCX
-12.28%
$33.51
VRN
-6.06%
$6.275
HBAN
-11.51%
$13.46
QBTS
-2.72%
$7.14
MSFT
-2.36%
$373.11
ET
-6.31%
$17.735
BABA
-0.30%
$129.4
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
NCLH
-16.36%
$16.31
RGTI
-4.00%
$8.15
MCHP
-16.80%
$40.71
ERIC
-3.98%
$7.48
TSM
-7.64%
$157.38
GOOG
-3.92%
$152.63
GRAB
-7.59%
$4.26
APLD
2.46%
$6.24
GAP
-20.29%
$17.84
CRWV
-12.32%
$53.8
NOK
-6.92%
$4.98
CX
-2.28%
$5.56
MARA
-9.58%
$11.23
WFC
-9.12%
$65.67
BCS
-9.02%
$14.32
PCG
-0.98%
$17.26
FSM
-2.40%
$6.09
MRVL
-12.00%
$55.64
KO
2.59%
$73.18
OXY
-11.01%
$43.9
VZ
2.03%
$45.6469
DMN
9.42%
$0.0151
NVDA
-7.81%
$101.8
INTC
2.05%
$22.43
F
-5.96%
$9.545
LCID
-3.33%
$2.32
STSS
8.79%
$0.0297
PTIX
84.14%
$0.418
LGMK
-15.96%
$0.0158
TSLA
-5.47%
$267.28
BAC
-11.06%
$37.22
NIVF
-4.75%
$0.561
MGOL
-20.43%
$0.37
DGLY
9.09%
$0.036
AAPL
-9.25%
$203.19
AMZN
-8.98%
$178.41
PLTR
-4.40%
$83.6
ALTM
0.00%
$5.84
OSRH
68.03%
$2.47
LILM
-36.97%
$0.052
AAL
-10.25%
$9.505
APVO
44.20%
$1.99
SOFI
-13.57%
$10.64
BON
-12.81%
$0.0633
NKE
-14.59%
$55.485
BTE
-10.54%
$1.995
GNPX
46.31%
$0.4316
HOOD
-10.36%
$38.26
DNN
-4.23%
$1.245
MULN
-22.82%
$0.0795
BBD
3.30%
$2.29
LYT
-16.78%
$0.0982
MRM
87.76%
$0.6947
PFE
-1.66%
$24.29
BTG
0.00%
$2.92
VALE
-3.57%
$9.73
WBD
-13.26%
$9.16
PMAX
-2.68%
$0.435
SNAP
-9.74%
$8.015
JYD
24.25%
$0.4293
AMD
-8.90%
$93.8
PLUG
-8.33%
$1.21
T
1.63%
$28.6
ABEV
2.54%
$2.42
CCL
-13.69%
$17.28
GOOGL
-4.02%
$150.72
MU
-16.09%
$74.34
SMCI
-7.89%
$32.32
AVGO
-10.51%
$154.01
RIG
-13.92%
$2.72
LYG
-4.56%
$3.665
CSCO
-7.30%
$57.31
C
-12.14%
$63.05
RIVN
-7.69%
$11.53
JBLU
-17.36%
$4.165
AGNC
-1.48%
$9.34
KSS
-22.79%
$6.64
NKLA
-28.74%
$0.183
NIO
-1.32%
$3.75
ITUB
2.71%
$5.68
UAA
-18.79%
$5.36
HPE
-15.23%
$13.665
ATPC
-0.78%
$1.28
TIVC
49.85%
$4.87
VFC
-28.80%
$11.67
AMCR
-2.50%
$9.555
META
-8.96%
$531.62
CLF
-16.90%
$7.255
WMT
-2.83%
$87.22
IQ
-4.57%
$2.09
STLA
-9.36%
$10.215
FCX
-12.28%
$33.51
VRN
-6.06%
$6.275
HBAN
-11.51%
$13.46
QBTS
-2.72%
$7.14
MSFT
-2.36%
$373.11
ET
-6.31%
$17.735
BABA
-0.30%
$129.4
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
NCLH
-16.36%
$16.31
RGTI
-4.00%
$8.15
MCHP
-16.80%
$40.71
ERIC
-3.98%
$7.48
TSM
-7.64%
$157.38
GOOG
-3.92%
$152.63
GRAB
-7.59%
$4.26
APLD
2.46%
$6.24
GAP
-20.29%
$17.84
CRWV
-12.32%
$53.8
NOK
-6.92%
$4.98
CX
-2.28%
$5.56
MARA
-9.58%
$11.23
WFC
-9.12%
$65.67
BCS
-9.02%
$14.32
PCG
-0.98%
$17.26
FSM
-2.40%
$6.09
MRVL
-12.00%
$55.64
KO
2.59%
$73.18
OXY
-11.01%
$43.9
VZ
2.03%
$45.6469
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.